Literature DB >> 718251

Levamisole and HBsAg positive chronic persistent hepatitis.

M Masi, P Paolucci, G Timoncini, M P Fantini, G Leggieri, F Chiodo, C Franceschi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 718251      PMCID: PMC1545093          DOI: 10.1136/adc.53.9.764

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  5 in total

1.  Levamisole in viral hepatitis.

Authors:  A Pár; K Barna; I Hollós; M Kovács; Z Miszlai; A Patakfalvi; T Javor
Journal:  Lancet       Date:  1977-03-26       Impact factor: 79.321

2.  Inadequate antibody response to hBAg or suppressor T-cell defect in development of active chronic hepatitis.

Authors:  A L Eddleston; R Williams
Journal:  Lancet       Date:  1974-12-28       Impact factor: 79.321

3.  Levamisole and human lymphocyte surface markers.

Authors:  J Wybran; A Govaerts
Journal:  Clin Exp Immunol       Date:  1977-02       Impact factor: 4.330

4.  Restoration by levamisole of low E-rosette forming cells in patients suffering from various diseases.

Authors:  H Verhaegen; J De Cree; W De Cock; F Verbruggen
Journal:  Clin Exp Immunol       Date:  1977-02       Impact factor: 4.330

5.  Potentiation of T-cell mediated immunity by levamisole.

Authors:  G Renoux; M Renoux; M N Teller; S McMahon; J M Guillaumin
Journal:  Clin Exp Immunol       Date:  1976-08       Impact factor: 4.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.